
Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long‐acting release
Author(s) -
Takenaka Kenchi,
Nishitani Rie
Publication year - 2019
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2139
Subject(s) - exenatide , medicine , type 2 diabetes mellitus , diabetes mellitus , type 2 diabetes , endocrinology
Key Clinical Message Two elderly patients with poorly controlled type 2 diabetes mellitus had difficulty self‐managing their medications. Exenatide long‐acting release (LAR), with an extended administration interval of 1 month, maintained hemoglobin A1c (HbA1c) level in the 7% range. Monthly administration of exenatide‐LAR may be considered for use in carefully selected elderly individuals.